April 9, 2013Letter Agreement • April 10th, 2013 • Infinity Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This letter agreement (this “Agreement”) confirms the agreement among Infinity Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Purdue Pharma L.P. (“Purdue”), Beacon Company (“Beacon”) and Rosebay Medical Company L.P. (“Rosebay” and, together with Purdue and Beacon, the “BRP Entities”) regarding certain matters related to the Securities Purchase Agreement dated as of July 17, 2012, among the Company and the BRP Entities (the “Purchase Agreement”), as set forth in greater detail below. Defined terms used herein but not otherwise defined herein shall have the meaning given to them in the Purchase Agreement.
